1. EP795 Searching for the best maintenance therapy in platinum-sensitive recurrent ovarian cancer: bevacizumab or PARP-inhibitors? A network meta-analysis. (1st November 2019) Authors: Bartoletti, M; Pelizzari, G; Bortot, L; Giavarra, M; Vitale, MG; Andreotti, V; Parnofiello, A; Scalone, S; Lombardi, D; Nicoloso, M; Bozza, C; Poletto, E; Sacco, C; Andreetta, C; Sorio, R; Puglisi, F Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗